Ibafloxacin

N/A

Report date: 2026/03/04 20:01:44

NME

Base Information

Drug NameIbafloxacin

Drug Alias NameS-25930R-835

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics

Mechanisms of ActionTopoisomerase II inhibitorsTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors

TargetsTopoisomerase IITopoisomerase IVBacterial DNA gyrase

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator Companies3m

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies3m Healthcare Ltd

Active IndicationsN/A

Inactive IndicationsBacterial Infections

ATC CodeN/A